5116 Financial Statements From 2010 to 2024
| 5116 Stock | 1.40 0.04 2.94% |
Check Al Aqar financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Al Aqar's main balance sheet or income statement drivers, such as , as well as many indicators such as . 5116 financial statements analysis is a perfect complement when working with Al Aqar Valuation or Volatility modules.
5116 |
Al Aqar Healthcare Company Revenue Analysis
Al Aqar's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Al Aqar Revenue | 114.07 M |
Most of Al Aqar's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Al Aqar Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Al Aqar Healthcare reported 114.07 M of revenue. This is 92.48% lower than that of the Real Estate sector and significantly higher than that of the Residential & Commercial REITs industry. The revenue for all Malaysia stocks is 98.79% higher than that of the company.
Al Aqar Healthcare Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Al Aqar's current stock value. Our valuation model uses many indicators to compare Al Aqar value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Al Aqar competition to find correlations between indicators driving Al Aqar's intrinsic value. More Info.Al Aqar Healthcare is number one stock in return on equity category among its peers. It also is the top company in current valuation category among its peers reporting about 189,937,111 of Current Valuation per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Al Aqar's earnings, one of the primary drivers of an investment's value.About Al Aqar Financial Statements
Al Aqar investors utilize fundamental indicators, such as revenue or net income, to predict how 5116 Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in 5116 Stock
Al Aqar financial ratios help investors to determine whether 5116 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 5116 with respect to the benefits of owning Al Aqar security.